RxDoctor Payments Data

Saket Sanghai, MD

Clinical Cardiac Electrophysiology · Portland, ORNPI 1265864474

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (40.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 58.0% of the total. Reporting peaked in 2019 at $24,899 and has fallen 83.4% since, to $4,124 in 2025.

$35,812in general payments, 2019–2025

Across 141 payments — averaging $253.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$21K
  • Abbott$7K
  • Boston Scientific$3K
  • Medical Device Business Services, Inc.$2K
  • Biotronik Inc.$2K
  • Biosense Webster, Inc.$971

What the payments were for

  • Consulting fees$2,0006%
  • Grants$14,36740%
  • Travel & lodging$13,06036%
  • Food & beverage$5,63416%
  • Education$7512%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)43$20,759
Abbott48$6,581
Boston Scientific18$3,245
Medical Device Business Services, Inc.15$2,183
Biotronik Inc.8$2,073
Biosense Webster, Inc.9$971

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,812 in reported general payments places this provider in the 75th percentile of 37 clinical cardiac electrophysiology providers in Oregon.

See all clinical cardiac electrophysiology providers in Oregon

Medicare billing

Part B allowed, 2024
$109,467
Medicare patients
1,277
Services billed
2,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$91,274
XareltoRivaroxaban15$17,185
Dofetilide23$3,147
Mexiletine Hcl16$2,786
Metoprolol Succinate55$1,215
Flecainide Acetate29$914
Amiodarone Hcl33$784
SotalolSotalol Hcl24$589
ClopidogrelClopidogrel Bisulfate15$275
Omeprazole11$71

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →